These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7821274)

  • 1. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
    Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
    Neurology; 1993 Dec; 43(12):2501-7. PubMed ID: 8255447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy.
    Provinciali L; Bartolini M; Mari F; Del Pesce M; Ceravolo MG
    Acta Neurol Scand; 1996 Jul; 94(1):12-8. PubMed ID: 8874587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?
    McKee PJ; Blacklaw J; Friel E; Thompson GG; Gillham RA; Brodie MJ
    Epilepsia; 1993; 34(5):937-43. PubMed ID: 8404750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C; Mosier M; Penry K
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
    Mattson RH; Petroff O; Rothman D; Behar K
    Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-vinyl GABA (vigabatrin) and mood disturbances.
    Aldenkamp AP; Vermeulen J; Mulder OG; Overweg J; Van Parys JA; Beun AM; Van 't Slot B
    Epilepsia; 1994; 35(5):999-1004. PubMed ID: 7925172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
    Bruni J; Guberman A; Vachon L; Desforges C
    Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group.
    Mauguière F; Chauvel P; Dewailly J; Dousse N
    Epilepsia; 1997 Mar; 38(3):301-8. PubMed ID: 9070592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
    Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin.
    Mumford JP; Cannon DJ
    Epilepsia; 1994; 35 Suppl 5():S25-8. PubMed ID: 8039466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily versus twice-daily vigabatrin: is there a difference? The results of a double-blind pilot study.
    Zahner B; Stefan H; Blankenhorn V; Krämer G; Richens A; Thümler R; Mumford JP
    Epilepsia; 1999 Mar; 40(3):311-5. PubMed ID: 10080511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA; Cuadrado A; Bravo J; Arteaga R
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin: clinical evidence supporting rational polytherapy in management of uncontrolled seizures.
    de Bittencourt PR; Mazer S; Marcourakis T; Bigarella MM; Ferreira ZS; Mumford JP
    Epilepsia; 1994; 35(2):373-80. PubMed ID: 8156960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin.
    Guberman A
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.